UBI — Universal Biosensors Cashflow Statement
0.000.00%
Last trade - 00:00- AU$17.29m
- AU$9.49m
- AU$6.28m
- 21
- 41
- 27
- 20
Annual cashflow statement for Universal Biosensors, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.64 | -10.5 | -26.9 | -6.74 | -14.2 |
| Depreciation | |||||
| Non-Cash Items | 0.544 | -0.498 | 11.7 | 0.284 | -0.483 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.63 | -1.46 | -2.29 | -9.13 | 1.62 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -8.29 | -9.9 | -14.7 | -14.6 | -12.3 |
| Capital Expenditures | -0.387 | -0.665 | -1.57 | -1.47 | -0.413 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.015 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.372 | -0.665 | -1.57 | -1.47 | -0.413 |
| Financing Cash Flow Items | — | — | — | -0.009 | -0.007 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.044 | 0.096 | 25 | -0.083 | 11.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.14 | -9.96 | 8.73 | -16.2 | -1.7 |